Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
AB-CHMINACA | | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karboxamid | |
AB-FUBINACA | | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | |
AB-PINACA | | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid | |
4-Acetoxy-N-methyl-N-ethyltryptamin | 4-AcO-MET | {3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát | |
o-Acetylpsilocin | 4-AcO-DMT | {3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}acetát | Psilacetin |
ADB-CHMINACA | | N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid | |
ADB-FUBINACA | | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | |
ADB-PINACA | | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid | |
| AH-7921 | 3,4-dichlor-7V-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | |
| AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinobn-9-karboxamid | 6-allyl-6-nor-LSD |
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon | |
AMB-FUBINACA | FUB-AMB | Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát | MMB-FUBINACA |
AMB-CHMICA | | Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát | |
5-Aminopropylindol | 5-API | 5-(2-aminopropyl)indol | |
APICA | SDB-001,2NEl | N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid | |
APINACA | | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | AKB48 |
| bk-PMA | 2-amino-1-(4-methoxy fenyl)propan-1-on | |
Methedron | bk-PMMA | 1-(4-methoxy fenyl)-2-(methylamino)propan-1-on | |
BMDP | 3,4-MDBC | 2-benzylamino-1-(3,4-methy lendioxy feny l)propan-1-on | |
2-Brommethkathinon | 2-BMC | (RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on | |
3-Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
4-Brommethkathinon | 4-BMC | (RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on | Brefedron |
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | Cimbi-36 |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-f(2-methoxyfenyl)methyllethanamin | 2C-C-NBOMe |
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-1-NBOH; Cimbi-27 |
| 25I-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | NB0Me-2C-I |
Bromo-Dragonfly | | (2R)-1-(4-bromfurof 2,3-f] [ 1 ]benzofuran-8-yl)propan-2-amin | |
Butylon | Bk-MBDB | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on | B1 |
2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
3-Chloramfetamin | 3-CA | 1-(3-chlorfenyl)propan-2-amin | |
4-Chloramfetamin | 4-CA | 1-(4-chlorfenyl)propan-2-amin | PCA |
4-Chlor-N-butylkathinon | 4-CBC | 2-(butylamino)-1-(4-chlorfenyl)propan-1-on | 4-Chlorbutylkathinon |
2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
3-Chlorethkathinon | 3-CEC | 1-(3-chlorfenyl)-2-(ethylamino)propan-1-on | |
4-Chlorethkathinon | 4-CEC | 1-(4-chlorfenyl)-2-(ethylamino)propan-1-on | |
4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methylN-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 2C-E | 2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin | |
2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
3-Chlormethamfetamin | 3-CMA | 1-(3-chlorfenyl)-N-methylpropan-2-amin | |
4-Chlormethamfetamin | 4-CMA | 1-(4-chlorfenyl)-N-methylpropan-2-amin | p-CMA |
2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
3-Chlormethkathinon | 3-CMC | 1-(3-chlorfenyl)-2-(methylamino)propan-1-on | |
4-Chlormethkathinon | 4-CMC | 1-(4-chlorfenyl)-2-(methylamino)propan-1-on | Clefedron |
2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
3-Chlorpentedron | 3-CPD | 1-(3-chlorfenyl)-2-(methylamino)pentan-1-on | |
4-Chlorpentedron | 4-CPD | 1-(4-chlorfenyl)-2-(methylamino)pentan-1-on | |
4-Chlor-α-pyrrolidinovalerofenon | 4-CI-α-PVP | 1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
CUMYL-4CN-BINACA | SGT-78 | 1-(4-kyanobuty l)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid | |
Cyklopentylfentanyl | Cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
Cyklopropylfentanyl | | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | |
Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
Dimethoxypropylthiofenethylamin | 2C-T-7 | [4-(propylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| CP-47,497 | 2-[(1R,3S)-3-hydroxycyklohexyl]-5-(2-methyloktan-2-yl)fenol | |
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 |
| DBZP | 1,4-dibenzylpiperazin | |
Deschlorketamin | | 2-(methylamino)-2-fenyl-cyklohexanon | |
Despropionyl-2-fluor fentanyl | | N-(2-fluorfeny 1)-1-(2-fenylethyl)piperidin-4-amin | |
Despropionyl-4-fluor fentanyl | | N-(4-fluorfeny 1)-1-(2-fenylethyl)piperidin-4-amin | |
Dibutylon | Bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon | Methylbutylon |
Diclazepam | 2-chlorodiazepam | 7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-di hydro-2H-1,4-benzodiazepin-2-on | Ro 5-3448 |
Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl]amin | |
Difenidin | DPD; 1,2-DEP; DIPH | 1-(1,2-difenylethyl)piperidin | AC1L4H21 |
5-Dihydrobenzofuranpyrovaleron | 5-DBFPV; MBPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
p-Methyl-4-methylaminorex | 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | p4-DMAR |
Dimethylheptyltetrahydrokanabinol | DMHP | 3-(l,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
2,3-Dimethylmetkathinon | 2,3-DMMC | 1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on | |
2,4-Dimethylmetkathinon | 2,4-DMMC | 1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
3,4-Dimethylmetkathinon | 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
2,5-Dimethoxy-4-chloramfetamin | DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | |
Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
Dimethoxymetamfetamin | SEP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
2,5-Dimethoxy-4-jodamfetamin | DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | |
| 5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin | |
| 6-EAPB | 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin | |
Dimethylon | Bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-on | 3,4-methylendioxydi-methylkathinon |
Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
Ephylon | MDEVP; bk-EBDP | 1-(benzo[dl] [ 1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on | N-ethyl-pentylon |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindol-[4,3-fg]chinolin-9-karboxamid | |
Etizolam | AHR 3219; Depas | 4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [ 1,2,4]triazolo[4,3-a] [ 1,4]diazepin | |
Ethyl feni dát | | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | |
2-Ethylmethkathinon | 2-EMC | (RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on | |
3-Ethylmethkathinon | 3-EMC | (RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on | |
4-Ethylmethkathinon | 4-EMC | (RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on | |
N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofenon |
Etryptamin | | 3-(2-aminobutyl)indol | |
2-Fluoramfetamin | 2-FA | 1-(2-fluorfenyl)propan-2-amin | |
3-F luoramfetamin | 3-FA | 1-(3-fluorfenyl)propan-2-amin | |
4-Fluoramfetamin | 4-FA | 1-(4-fluorfenyl)propan-2-amin | |
5F-ADBICA | | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | |
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | |
5F-AMB-PINACA | 5F-AMB | Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP |
Fentanyl butanamid analog | Butyrfentanyl | N-fenyl-N-[ 1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
3F-Fenmetrazin | 3-FPM; PAL-593 | 2-(3-fluorofenyl)-3-methylmorfobn | |
4F-Fenmetrazin | 4-FPM | 2-(4-fluorofenyl)-3-methylmorfobn | |
4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorofenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
2-Fluorethkathinon | 2-FEC | 1-(2-fluorfenyl)-2-(ethylamino)propan-1-on | |
3-Fluorethkathinon | 3-FEC | 1-(3-fluorfenyl)-2-(ethylamino)propan-1-on | |
4-Fluorethkathinon | 4-FEC | 1-(4-fluorfenyl)-2-(ethylamino)propan-1-on | |
2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[ 1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyllpropanamid | 3-FF, m-FF |
4-Fluorisobutyrfentanyl | 4F-ÍBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
2-Fluormethamfetamin | 2-FMA | (RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin | |
3-Fluormethamfetamin | 3-FMA | (RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin | |
4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
2-Fluormethkathinon | 2-FMC | 1-(2-fluorfenyl)-2-(methylamino)propan-1-on | |
3-Fluormethkathinon | 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | |
4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron |
4-Fluormethylfenidát | 4F-MPH; 4-FMPH | Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | 4F-TMP |
4-Fluorpentedron | 4-FPD; 4-F-pentedron | 1-(4-fluorfenyl)-2-(methylamino)pentan-1-on | |
| 5F-PB-22; 5F-QUPIC | 8-chinolinyl ester kyseliny 1-(5-fluorpentyl)-1H-indol-3-karboxylové | |
5F-MDMB-PINACA | 5F-ADB | methyl (S)-2-({[1-(5-fhiorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | |
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | XLR-11 |
Furanylfentanyl | FU-F | N-fenyl-N-[ 1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | 2-furanoylfentanyl |
4-Hydroxy-N-methyl-v-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Methylcybin |
4-Hydroxy-N-methyl-N-isopropyl tryptamin | 4-HO-MiPT | 3-{ 2-[methyl(propan-2-yl)amino] ethyl}-1H-indol-4-ol | Miprocin |
Hydroxytenamfetamin | | (2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
(iso)Butyryl-F-fentanyl N-benzyl analog | | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | |
Joddimethoxyfenethylamin | 2C-I | (4-jod-2,5-dimethoxyfenylethyl)amin | |
| JWH-018 | (naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-073 | (1-butyl-1N-indol-3-yl)(naftalen-1-yl)methanon | |
| JWH-081 | (4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-i ndol-3-y 1 )methanon | |
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | |
| JWH-210 | (4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-250 | 2-(2-methoxy fenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | |
| JWH-398 | (4-chlomaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
Kathinon | | (2S)-2-amino-1-feny lpropan-1-on | |
(+)-Lysergid | LSD, LSD-25 | (+)-8ß-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 1p-LSD, 1P-LAD | diethylamid kyseliny 1-propionyl lysergové; (6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid | |
| 5-MeO-MiPT | N-[2-(5-methoxy-H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-methoxy-N-methyl-N-iso-propyl tryptamin | |
Methoxfenidin | MXP | 1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin | 2-MeO-difenidin |
Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
3-Methylamfetamin | 3-MA | (2RS)-1-(3-methylfenyl)propan-2-amin | |
4-Methylamfetamin | 4-MA | (2RS)-1-(4-methylfenyl)propan-2-amin | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | |
| 3-MAPB | 1-(benzofuran-3-yl)-N-methylpropan-2-amin | |
| 4-MAPB | 1-(benzofuran-4-yl)-N-methylpropan-2-amin | |
| 5-MAPB | 1-(benzofuran-5-yl)-N-methylpropan-2-amin | |
| 6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amin | |
| 7-MAPB | 1-(benzofuran-7-yl)-N-methylpropan-2-amin | |
| MBZP | 1-benzyl-4-methylpiperazin | |
2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
3-Methyl-N, N-dimethylkathi non | 3-MDMC | 1-(3-methylfenyl)-2-(dimethylamino)propan-1-on | |
4-Methyl-N,N-dimethylkathinon | 4-MDMC | 1-(4-methylfenyl)-2-(dimethylamino)propan-1-on | |
m-Chlorfenylpiperazin | mCPP | 1-(3-chlorfenyl)piperazin | |
Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| MDAI | 5,6-(methylendioxy)indan-2-amin | |
Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxy fenyl)propan-1-on | |
Methyltenamfetamin | MDMA | (2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
MDMB-CHMICA | | N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methylester | |
MDMB-FUBINACA | | 2-[[1 1-[(4-fluorfenyl)methyl] indazol-3-karbonyl] amino]-3,3-dimethylbutanoát | |
| MDPHP; 3,4-MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | |
2,3-Methylendioxymethkathinon | 2,3-MDMC | 1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on | |
3,4-Methylendioxypyrovaleron | MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | MDPK |
2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
3-Methylethkathinon | 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | |
4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
4-Methylmetkathinon | Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | |
5-MeO-AMT | | 5-methoxy-a-methyltryptamin | |
4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl] butanamid | |
5-MeO-DALT | | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin | |
3-Methoxy fencyklidin | 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | |
Meskalin | | 3,4,5-trimethoxyfenethy lamin | |
Methoxetamin | MXE | 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon | |
Methylaminorex | | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | |
α-Methylfentanyl butanamid analog | BF; B-F | 2-methy 1-N-feny 1-N-[ 1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
3-Methyl-N-ethylnorpentedron | 3-MEAP | 2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on | |
4-Methyl-N-ethylnorpentedron | 4-MEAP | 2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on | |
Methylon | Bk-MDMA | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | |
2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
3-Methylmetamfetamin | 3-MM A | 1-(3-methylfenyl)-N-methylpropan-2-amin | |
4-Methylmetamfetamin | 4-MMA | 1-(4-methylfenyl)-N-methylpropan-2-amin | |
2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
3-Methylmetkathinon | 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | |
Methoxytenamfetamin | MMDA | (27?5)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| 4-MPD | 1-(4-methylfenyl)-2-methylamino-pentan-1-on | |
Methylthienylpropamin | MPA | N-methyl-1-(thiofen-2-yl)propan-2-amin | |
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | |
2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
3-Methylthioamfetamin | 3-MTA | (2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin | |
4-Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
Mexedron | 4-MMC-oMe; MEX | (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on | |
Naftylpyrovaleron | Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | O-2482 |
N-methyl-2-aminoindan | N-methyl-2AI | 2,3-dihydro-N-methyl-1H-inden-2-amin | NM-2AI |
| NM-2201, CBL-2201 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát | |
OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yllacetamid | |
o-Desmethyltramadol | ODT | 3-{-2-[(dimethylamino)methyl]-1-hydroxy cyklohexyl} fenol | |
Parahexyl | | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
Pentedron | pentedron | 1-fenyl-2-(methylamino)pentan-1-on | |
p-Fluorfenylpiperazin | pFPP | 1-(4-fluorfenyl)piperazin | |
Methoxyamfetamin | PMA | (2RS)-1-(4-methoxy fenyl)propan-2-amin | |
Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
Psilocybin | | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogenfosfát | |
Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| PV8, α-PHPP | 1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on | |
| PV9, α-POP | 1-fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | |
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | |
α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
α-Pyrrolidinoisohexanofenon | α-PiHP | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexyl)pyrrolidin | |
Salvinorin A | Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS, 10aRS, 10bR)-9-acetoxy-2-(furan-3-yl)-6a, 10b-dimethyl-4,10-dioxododekahydro-1H-benzo[f]isochromen-7-karboxylát | |
Tenocyklidin | TCP | 1-[ 1-(2-thienyl)cyklohexyl]piperidin | |
1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6a(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
TH-PVP | | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | |
Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
Trimethoxyamfetamin-2 | TMA-2 | (2 RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
2,4,6-Trimethoxyamfetamin | TMA-6 | 1-(2,4,6-trimethoxyfenyl)propan-2-amin | |
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 |
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | |
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | |
| U-51,754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | |
Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl] pentanamid; fentanyl pentanamid analog | |
| W-15 | 4-chlor-N-(1-fenethylpiperidin-2-ybden)benzensulfonamid | |
| W-18 | 4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-ybden)benzensulfonamid | |
Včetně stereoizomerů psychotropních látek, až na výslovné výjimky, uvedených v tomto seznamu ve všech případech, kdy tyto stereoizomery mohou existovat podle zvláštního chemického označení a solí psychotropních látek uvedených v tomto seznamu ve všech případech, kdy mohou existovat.